CareDx Taps DNAnexus to Support Cell-Free Assay, Other Activities | GenomeWeb

NEW YORK (GenomeWeb) – Molecular diagnostics company CareDx has selected DNAnexus' cloud-based bioinformatics infrastructure to handle data from its proprietary next-generation sequencing-based cell-free DNA transplant assay, which is scheduled for release later this year.

DNAnexus' platform will also support ongoing research and development activities at CareDx as well as the company's clinical trials and registries, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.